PORTAL VEIN THROMBOSIS

This study looks at whether the blood thinner apixaban can safely clear blood clots in the portal vein that appear more than a year after spleen removal surgery. It involves 20 adults with cirrhosis who had their spleen removed. The main goal is to see if the clots fully dissolve…

This study tests whether adding a blood thinner (apixaban) to a standard heart drug (carvedilol) can prevent serious complications like internal bleeding, fluid buildup, and liver failure in people with cirrhosis and high blood pressure in the liver. About 220 adults with stable …

This study looks at whether the blood thinner apixaban can safely dissolve blood clots in the main vein of the liver (portal vein) that appear more than a year after spleen removal surgery. The trial involves 20 adults with cirrhosis who had this surgery. Researchers will measure…

This study follows 700 adults receiving a liver transplant to understand how portal vein thrombosis (blood clots in a major liver vein) affects their recovery and survival. Researchers will compare those with and without clots before surgery to identify risk factors and build a t…

This study follows 2,000 people with severe liver-related high blood pressure who are getting a TIPS procedure—a small tube placed in the liver to reroute blood flow. Researchers will track survival, need for liver transplant, and complications like confusion or liver failure ove…

This study looks at people with cirrhosis (scarred liver) who also have a blood clot in the main liver vein and enlarged veins in the stomach. Researchers want to find out what helps these clots dissolve over time. The goal is to help doctors and patients better understand the di…